|
SPAZO2 (SOGUG): Outcomes of patients treated with pazopanib as first line in mRC according to gender in real world. |
|
|
No Relationships to Disclose |
|
Javier Luis Puertas Alvarez |
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer; Eisai; GlaxoSmithKline; Hospira; Janssen; Lilly; Novartis; Pfizer; PharmaMar; Roche |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer |
|
|
No Relationships to Disclose |
|
Maria Jose Miranda Pallares |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Pfizer |
Speakers' Bureau - NOVARTIS; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Janssen Oncology; Novartis; Pfizer |
Speakers' Bureau - LEO Pharma; Novartis; Pfizer; Rovi; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; Novartis; Pfizer; Pierre Fabre |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Jose Luis Gonzalez Larriba |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Novartis; Pfizer; Pierre Fabre |
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; Novartis; Pfizer; Sanofi |
Research Funding - GlaxoSmithKline (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma |